Thank you for your interest in the 2023 NCEAS Annual Conference. Below are some of the conference details you will find on this page. Be sure to check back often for conference updates!
Below are some of the conference details you will find on this page. Be sure to check back often for conference updates!
I’m Registered, Now What?
We are using Dryfta as our conference platform this year. if you have not already registered please visit our site to register. You will need to create an account to register and purchase tickets for the conference.
View the 2023 NCEAS Conference program here!
CME
The AAFP has reviewed 2023 NCEAS Annual Conference and deemed it acceptable for up to 7.00 Live AAFP Prescribed credits. Term of Approval is from 02/27/2023 to 03/01/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificates of Participation
If you are a AAFP member you may report CME credits by clicking the link below and enter “2023 NCEAS Annual Conference” in the search bar.
If you are not a member of the AAFP, please download and complete the certificate below.
Early Bird Rate (before January 31st) |
Regular Registration Rate |
|
Community Member/Staff/Trainee/Student |
$55.00 | $70.00 |
Health Care Professional |
$165.00 | $195.00 |
Conference Refund and Cancellation Policy
The NCEAS Annual Conference Cancellation and Refund Policy will be as follows to assure consistency.
- Conference registration canceled on-line on or before February 17, 2023 will receive a 90% refund.
- Registrants canceling after February 17, 2023 will not receive a refund.
- In the event NCEAS must cancel the conference due to unforeseen circumstances, NCEAS will refund the cost of registration. However, NCEAS does not assume responsibility for any additional costs, charges, or expenses.
Monday, February 27th
1:00-5:00pm (CST)
Tuesday, February 28th
8:00-12:00pm (CST)
Wednesday, March 1st
1:00-5:00pm (CST)
Reshma Jagsi, M.D., D.Phil
Dr. Jagsi is Newman Family Professor and Deputy Chair in the Department of Radiation Oncology and Director of the Center for Bioethics and Social Sciences in Medicine at the University of Michigan; in November 2022, she will become the Chair of the Department of Radiation Oncology at Emory University. Gender equity in academic medicine has been a key area of her scholarly focus, a subject to which she brings her perspective as a physician and social scientist to promote evidence-based intervention. Author of over 400 articles in peer-reviewed journals, including multiple high-impact studies in journals such as the New England Journal of Medicine, the Lancet, and JAMA, her research to promote gender equity has been funded by R01 grants from the National Institutes of Health as well as large independent grants from the Doris Duke Foundation and several other philanthropic foundations. She has mentored dozens of others in research investigating women’s under-representation in senior positions in academic medicine and the mechanisms that must be targeted to promote equity. Active in organized medicine, she has served on the Steering Committee of the AAMC’s Group on Women in Medicine in Science and now serves on the National Academies of Science, Engineering, and Medicine’s Committee on Women in Science, Engineering, and Medicine. She was part of the Lancet’s advisory committee for its theme issue on women in science, medicine, and global health, which served to foster additional research. Also an internationally recognized clinical trialist and health services researcher in breast cancer, her work is frequently featured in the popular media, including coverage by the New York Times, Wall Street Journal, and NPR. Frequently invited as a keynote speaker, she has delivered countless invited talks to other institutions and professional societies, including the AAMC, the NIH, and the National Academy of Medicine and National Academy of Sciences. Her contributions have been recognized with her election to the American Society of Clinical Investigation and Association of American Physicians, the Leadership Award of the AAMC’s Group on Women in Medicine and Science, LEAD Oncology’s Woman of the Year Award, AMWA’s Woman in Science Award, and AMSA’s Women Leaders Award. She is a fellow of ASCO, ASTRO, AAWR, and the Hastings Center.
Nancy Denizard-Thompson, MD
Dr. Denizard-Thompson is an Associate Professor of General Internal Medicine at Wake Forest School of Medicine. She joined faculty in 2006 after completing a residency and chief residency at Vanderbilt and, almost immediately, assumed important leadership roles in the residency program, first as Director of Ambulatory Education and then as Associate Program Director. Dr. Denizard-Thompson has played large roles in institutional efforts to promote diversity and in developing innovative curricula in ambulatory medicine and curricula to address social determinants of health and healthcare disparities. These latter efforts have been supported by awards from the AMA, ACP, AHEC, and Fullerton Foundation. She currently Co-Directs the Longitudinal Health Equity curriculum at the School of Medicine, a Health Equity elective for 4th year students, and a Health Equity Certificate program for the Medical Center. In July she was appointed Vice Chair of Faculty Development for the Department of Internal Medicine. Her efforts have been recognized by a number of awards, including the WFBH Hero Award for Diversity and Inclusion, the Department of Internal Medicine Educator Award, and the Leonard Gold Humanism Faculty Award.
Angela Amar, PhD, RN, FAAN
Dr. Amar is Dean and Professor in the School of Nursing at the University of Nevada, Las Vegas. Prior to this, she was Associate Dean for Undergraduate Education at Emory University and was on the faculty in the schools of nursing at Boston College and Georgetown University. Dr. Amar has dedicated her career to enhancing diversity in nursing leadership and to improving care and support for survivors of violence and trauma, particularly increasing help seeking behavior with dating violence. She is a noted scholar on dating violence and sexual assault who has conducted funded research and published many articles and book chapters related to violence and diversity. Dr. Amar is a fellow in the American Academy of Nursing, a Distinguished Fellow with the International Association of Forensic Nurses, and a Fellow in the National League for Nursing’s Academy of Nursing Education. Dr. Amar is on the Board of Directors of the American Academy of Nursing, the Finance Committee of the National League of Nursing, and the chair of the Governance Committee of the American Association of Colleges of Nursing. Dr. Amar was co-author on an award winning book, A Practical Guide to Forensic Nursing. Dr. Amar’s family relocated in January and are enjoying their recently adopted boxer puppy, Brody. She is originally from New Orleans, enjoys travel and is an avid reader.
Gary Slutkin, MD
Dr. Slutkin is a World Health Organization (WHO) physician and epidemiologist who led efforts to combat epidemics in over 25 countries in east and central Africa, Latin America, and Asia. At the WHO he founded the Intervention Development Unit, which designed innovations and new innovations in epidemic control. He then adapted epidemic control methods to violence – founding and leading Cure Violence Global, rated as the #9 NGO in the world, and rated the #1t NGO for reducing violence in the world. Dr. Slutkin is credited with discovering and revealing the basis for fully re-diagnosing violence – as a contagious disease – and for proving by multiple independent studies – that treating violence as an epidemic disease is scientifically shown to work.
Dr. Slutkin received his M.D. from the University of Chicago, and completed his residency, and infectious disease training at University of California San Francisco (UCSF) and San Francisco General Hospital, where he was also Chief Resident in Medicine. He then served as Director of Tuberculosis Control for the City of San Francisco. Following wars in East Africa, he moved to Somalia to help guide efforts to reverse epidemics of tuberculosis and cholera in 40 refugee camps, leaving when civil war threatened Somalia. He was then recruited as one of the founding members of the WHO Global Programme on AIDS where he was assigned to start the country-wide program in Uganda, the most heavily affected country in the world, and then for the 12 other countries in central and east Africa – at the epicenter of the global epidemic. At WHO, he was also assigned to design and set up the system used for estimating the magnitude and trends of HIV globally and for setting the priorities for the joint TB and AIDS global collaboration.
On returning to the U. S. in the mid-1990s, Dr. Slutkin saw violence as a standard health epidemic and designed the methods now used in much of the United State and Latin America for reversing violence epidemics. His work with Cure Violence Global has achieved 40 – 70% drops in violence, sometimes to 100%, using epidemic control methods.
Dr. Slutkin is currently focused on more broadly educating the public on this fundamentally new view of violence and these new methods, including the writing of the book. “The End of Violence”. He is currently working with former UN staff and senior mediators of the Harvard Project on Negotiation and others to interrupt the war in Europe.
Dr. Slutkin’s work has been featured as the NY Times Sunday Magazine Cover Story, the award-winning documentary film, “The Interrupters”, and in over a dozen books. He has appeared on CNN, 60 Minutes, BBC The PBS News Hour, and dozens of other television and radio stations. He has been quoted in the NY Times, Wall Street Journal, Financial Times, The Economist, Washington Post, USA Today, The Guardian, US News and World Report, New Scientist, Wired, and other leading publications. Dr. Slutkin speaks regularly at global, national, and local forums including The World Bank, Institute of Medicine, World Economic Forum, the UN, the White House, Dept of Justice, State Department, Pentagon, and multiple universities including Harvard University School of Law, MIT Saxe Lab, UCSF, UC Berkley, Johns Hopkins and others, as well as corporate, religious, health and other conferences.
